Keeping Track: We're Back!
Executive Summary
The latest drug development news and highlights from our US FDA Performance Tracker.
You may also be interested in...
Keeping Track: An Approval For Ajovy, A CRL For Ruconest, And Some Submissions from J&J
The latest drug development news and highlights from our US FDA Performance Tracker.
Keeping Track: Shionogi, Fresenius Kabi Join July Approval Parade; Busy August Expected
The latest drug development news and highlights from our US FDA Performance Tracker.
Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year
Public Company Edition: Nine more biopharma companies launched IPOs in the US in July, bringing the 2018 total to 45 first-time offerings – three more than in all of 2017. Bluebird's $632.5m offering leads recent follow-on public offerings.